| Product Name | NebuSelect™ Recombinant Cynomolgus LY6G6D, hFc-tag |
|---|---|
| Catalog Number | NBL-241145 |
| Alias/Synonyms | LY6G6D |
| Appearance | see COA |
| Molecule Weight | Asn20-Ser104 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | XP_014991478.1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-241145-100ug | 100ug | Inquire | Inquire | |
| NBL-241145-1mg | 1mg | Inquire | Inquire | |
| NBL-241145-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Cynomolgus LY6G6D, hFc-tag
Catalog#:
NBL-241145
Description:
NebuSelect™ Recombinant Cynomolgus LY6G6D, hFc-tag(Cat#NBL-241145) is expressed in HEK293 with hFc tag at the N-terminus.It contains Asn20-Ser104.
Species:
Cynomolgus
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 34.65 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on Bis-Tris PAGE result.
Target Name:
LY6G6D
Target Information:
LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.LY6G6D was identified as a selectively expressed CRC antigen that can be utilized to potently re-direct and activate cytotoxic T-cells to lyse LY6G6D expressing CRC using a TcE. This effect can be spread to target negative neighboring tumor cells, potentially leading to improved therapeutic efficacy.
Amino Acid Sequence:
Asn20-Ser104
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.